Kriti Mehrotra
While Cindy Eckert is no stranger to the limelight, given her entrepreneurial work in pharmaceuticals, she has received significant attention for her advocacy in the past few years alone. Paramount+’s ‘The Pink Pill: Sex, Drugs & Who Has Control’ sheds light on the fact that she has been advocating for and working towards advancements in women’s sexual health since the early 2010s. Throughout the process, she has admittedly faced several ups and downs, but she vehemently continues on the path she has carved for herself with the sole aim of helping others.
How Did Cindy Eckert Earn Her Money?
A native of New York, Cindy Eckert spent most of her childhood abroad alongside her father, who was a US Ambassador to Fiji, which ingrained in her a strong global perspective. She maintained this standing as she returned to the US at age 18 to pursue a Bachelor’s degree in Business Administration at Marymount University in Arlington County, Virginia. Six months after her graduation in 1994, she bagged a job at one of the world’s largest drug companies, Merck. Cindy shared that she had no passion for pharmaceuticals at the time, but she had realized while earning her degree that brand names/reputations matter a lot, so she deemed it the best possible outcome. She served there for a few years before heeding her brother’s advice and leaving the corporate world to find her calling with a smaller team, focusing on efficiency.
Cindy subsequently joined the specialty pharmaceutical companies Dura and Elan, only to soon shift gears and work at an advertising agency, McCann Erickson, and later at QVC to build better brand connections. In the end, in 2005, Cindy and her then-husband, Bob Whitehead, decided to move to Raleigh, North Carolina, where they established their own pharmaceutical company. Slate Pharmaceuticals was their first endeavor in 2007, during which they developed a long-acting, Food and Drug Administration (FDA)- approved testosterone pellet called Testopel. Everything seemed to be going great, but things changed in 2010 after the FDA issued them a warning concerning their marketing practices.
The pair ultimately sold the business to Actient in 2011. By that point, Cindy and Bob had also established Sprout Pharmaceuticals, which they used to focus on women’s sexual health, desire, needs, and more through a then-experimental drug. Addyi (inspired by Kate Walsh’s character on ‘Grey’s Anatomy) was in the early phases at the time, but Cindy worked hard to ensure it was safe and spent the ensuing 4 years towards the “Pink Pill.” After 2 failed attempts, the so-called female Viagra to boost a woman’s sex drive was finally approved by the FDA in 2015 – it got a 16-8 positive vote – resulting in its quick launch.
It was not long after FDA approval that Sprout was acquired by Valeant Pharmaceuticals, which promised to keep the original Addyi team on board and invest in its sales. However, as per the show, Valeant soon became embroiled in its own massive corporate and drug-pricing scandal. Amidst all the turbulence, the Sprout team was reportedly sidelined, and Cindy lost the title of CEO. In the time that followed, she established a “Pinkubator” and a venture investment/consulting firm called The Pink Ceiling in 2016, and later reportedly sued Valeant for breach of contract. In November 2017, Cindy reacquired Sprout Pharmaceuticals, reportedly citing it as a settlement to drop her case, which allowed her to regain all her hard work and the title of CEO.
Cindy Eckert’s Net Worth
Since Cindy Eckert has been a significant player in the corporate world, the pharmaceutical industry, and female entrepreneurship over the past couple of decades, it goes without saying that she has accumulated significant wealth. Unfortunately, it is almost impossible to calculate her precise income and profits over the years, as she has understandably preferred to keep her financial details well out of the limelight. However, we do have some estimates. Based on her qualifications, industry standards, and her hard work when she first kick-started her career, she likely walked away with a salary of at least $50,000 per year in the mid to late 1990s.
Then, with Cindy able to work in low-level pharmaceuticals, advertising, and QVC, she bagged around $ 50,000 to $60,000 in the early 2000s before launching her own business. With the success of Slate Pharmaceuticals in male sexual health and Sprout Pharmaceuticals in female sexual health, it appears that she and her co-owner husband likely made millions by the late 2000s. Then, the couple sold Slate to Actient Pharmaceuticals for a whopping $500 million in 2011 and Srpout to Valeant Pharmaceuticals for an even more astounding $1 billion in 2015.
By this point, having parted ways with Bob Whitehead, Cindy was reportedly running the show mostly on her own, so she suffered with all the controversies surrounding the “Pink Pill.” Nevertheless, she persevered and launched her Pink Ceiling investment firm and incubator to support female-led organizations in any capacity, which helped her get back on her feet. As of writing, Pink Ceiling has invested in over 11 start-ups, including Undercover Color, Lia Diagnostics, and Pursuit, and when Sprout Pharmaceuticals came back to Cindy, she acquired it under the umbrella of her investment firm. Thus, taking all these aspects into consideration, Cindy’s current standing as CEO, her social media presence, her advocacy work, her potential assets, investments, and returns, and her lifestyle in Raleigh, North Carolina, we believe she has a net worth of $2 billion.
Read More: What is Julia Haart’s Net Worth?
